Company news

CRISPR Therapeutics AG news in 2026

CRISPR Therapeutics AG's news releases, calls and decks from 2026, newest first.

View company

CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition

November 4, 2026

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results

November 2, 2026

CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer

November 2, 2026

CRISPR Therapeutics Announces Chief Financial Officer Transition

October 19, 2026

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026

October 8, 2026

CRISPR Therapeutics to Present Clinical Data on Zugocabtagene Geleucel (Zugo-cel) in Autoimmune Disease at the American College of Rheumatology (ACR) Convergence 2026

October 2, 2026

CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

September 8, 2026

CRISPR Therapeutics Presents Phase 1a Data for CTX310 Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026

August 31, 2026

CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026

August 28, 2026

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

August 3, 2026

CRISPR Therapeutics to Present at the Bank of America Securities 2026 Global Healthcare Conference

May 6, 2026

CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

May 4, 2026

Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR

April 20, 2026

CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

April 6, 2026

CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering

March 10, 2026

CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering

March 9, 2026

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

February 12, 2026

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

February 11, 2026

CRISPR Therapeutics Highlights Strategic Priorities and Anticipated 2026 Milestones

January 12, 2026

CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 4, 2026

Decks in 2026